Paola Arbour Sells 6,500 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Paola Arbour sold 6,500 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Tenet Healthcare Stock Performance

THC opened at $227.79 on Friday. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The stock has a market cap of $19.81 billion, a P/E ratio of 14.71, a P/E/G ratio of 1.12 and a beta of 1.39. The stock’s 50 day simple moving average is $213.46 and its 200 day simple moving average is $204.15. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare’s revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank purchased a new stake in shares of Tenet Healthcare during the 4th quarter valued at about $248,494,000. Eminence Capital LP acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $225,263,000. Boston Partners raised its stake in shares of Tenet Healthcare by 95.0% during the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares during the period. Wellington Management Group LLP lifted its position in shares of Tenet Healthcare by 1,114.2% during the fourth quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares in the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after purchasing an additional 720,160 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on THC. Guggenheim lifted their target price on shares of Tenet Healthcare from $271.00 to $283.00 and gave the stock a “buy” rating in a research report on Thursday. Truist Financial lifted their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Mizuho upped their target price on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Finally, Royal Bank Of Canada upped their price objective on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $250.56.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.